WASHINGTON — The Trump administration’s unprecedented approach to overseeing the health industry seems to be working — at least some of the time.
Administration officials aren’t enacting regulations or pushing Congress to write laws to tackle some of their top priorities. Instead, they’re demanding companies take voluntary action, offering incentives for those who comply and promising harsh penalties for those who don’t.
Officials have characterized the approach as more industry-friendly: allowing the private sector to make its own choices before any rules and regulations are drafted. Plus, it lets President Trump declare quick wins in the first months of his second term.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Individual plans
Group plans
To read the rest of this story subscribe to STAT+.